Literature DB >> 24224590

From the radiologic pathology archives: organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia.

Seth J Kligerman1, Teri J Franks, Jeffrey R Galvin.   

Abstract

Organization, characterized by fibroblast proliferation, is a common and nearly universal response to lung injury whether it is focal or diffuse. Despite the vast range of injurious agents, the lung's response to injury is quite limited, with a similar pattern of reaction seen radiologically and histologically regardless of the underlying cause. Although there is a tendency to divide organization into distinct entities, the underlying injury to the alveolar epithelial basement membrane is a uniting factor in these processes. This pattern of lung injury is seen in the organizing phase of diffuse alveolar damage, organizing pneumonia (OP), acute fibrinous and organizing pneumonia, and certain types of fibrotic lung disease. In addition, although organization can heal without significant injury, in some instances it progresses to fibrosis, which can be severe. When fibrosis due to organization is present, other histologic and imaging patterns, such as those seen in nonspecific interstitial pneumonia, can develop, reflecting that fibrosis can be a sequela of organization. This article reviews the histologic and radiologic findings of organization in lung injury due to diffuse alveolar damage, OP, and acute fibrinous and organizing pneumonia and helps radiologists understand that the histologic and radiologic findings depend on the degree of injury and the subsequent healing response. © RSNA, 2013.

Entities:  

Mesh:

Year:  2013        PMID: 24224590     DOI: 10.1148/rg.337130057

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  56 in total

1.  Pediatric Acute Respiratory Distress Syndrome and Hypersensitivity Pneumonitis Related to E-cigarette Vaping.

Authors:  Binh Phung; Anh Lam
Journal:  J Pediatr Intensive Care       Date:  2019-11-28

2.  Organizing Pneumonia as a Histopathological Term.

Authors:  Fatma Tokgöz Akyıl; Meltem Ağca; Aysun Mısırlıoğlu; Ayşe Alp Arsev; Mustafa Akyıl; Tülin Sevim
Journal:  Turk Thorac J       Date:  2017-07-01

3.  Diagnostic clues of organizing pneumonia: a case presentation.

Authors:  Gaetano Rea; Maria Pignatiello; Luca Longobardi; Angela Barbieri; Salvatore Cappabianca; Tullio Valente
Journal:  Quant Imaging Med Surg       Date:  2017-02

4.  The Reversed Halo Sign and COVID-19: Possible Histopathological Mechanisms Related to the Appearance of This Imaging Finding.

Authors:  Anderson Ribeiro de Sales; Emerson de Melo Casagrande; Bruno Hochhegger; Glaucia Zanetti; Edson Marchiori
Journal:  Arch Bronconeumol       Date:  2020-07-27       Impact factor: 4.872

5.  Focal Mediastinitis and Pulmonary Arterial Thrombosis after EBUS-TBNA.

Authors:  Andrea Palomeque; Ivan Vollmer; Ainhoa Fontana; Carmen M Lucena; Carles Agustí
Journal:  Arch Bronconeumol (Engl Ed)       Date:  2020-08-11       Impact factor: 4.872

6.  Aspiration-related organizing pneumonia complicating laparoscopic adjustable gastric banding: A lung cancer mimicker.

Authors:  Ahmed A Aljohaney; Amr M Ajlan; Fahad A Alghamdi
Journal:  Ann Thorac Med       Date:  2016 Oct-Dec       Impact factor: 2.219

Review 7.  Illustration of a number of atypical computed tomography manifestations of active pulmonary tuberculosis.

Authors:  Yi Zeng; Xiao-Li Zhai; Yì Xiáng J Wáng; Wei-Wei Gao; Chun-Mei Hu; Fei-Shen Lin; Wen-Shu Chai; Jian-Yun Wang; Yan-Ling Shi; Xin-Hua Zhou; Hui-Shan Yu; Xi-Wei Lu
Journal:  Quant Imaging Med Surg       Date:  2021-04

8.  Diagnostic procedures and clinico-radiological findings of acute fibrinous and organizing pneumonia: a systematic review and pooled analysis.

Authors:  Jong Hyuk Lee; Ho-Kee Yum; Fady Jamous; Cláudia Santos; Alessio Campisi; Salim Surani; Filippo Lococo; Jin Mo Goo; Soon Ho Yoon
Journal:  Eur Radiol       Date:  2021-03-31       Impact factor: 5.315

9.  Clinical and radiological characteristics of e-cigarette or vaping product use associated lung injury.

Authors:  Ambika G Chidambaram; Rebecca A Dennis; David M Biko; Marcus Hook; Julian Allen; Jordan B Rapp
Journal:  Emerg Radiol       Date:  2020-05-28

Review 10.  Immune Checkpoint Immunotherapy for Non-Small Cell Lung Cancer: Benefits and Pulmonary Toxicities.

Authors:  Karthik Suresh; Jarushka Naidoo; Cheng Ting Lin; Sonye Danoff
Journal:  Chest       Date:  2018-09-04       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.